Testing for carcino-embryonicantigen (CEA) in the blood is a recommended part of follow-up to detect recurrence of colorectal cancer following primary curative treatment.
检测血液中的癌胚抗原（CEA）作为在主要治疗后，追踪侦测大肠癌复发的建议检测。
2
Based on the comprehensive embryonic genome, we effectively performed whole-genome Mendelian disorder diagnosis and human leukocyte antigen matching tests.